Document is current
Any future updates will be listed below
-
Authors
Richard, Shambavi https://orcid.org/0000-0003-0274-4292
Lesokhin, Alexander M.
Paul, Barry
Kaufman, Jonathan L.
Pianko, Matthew
Biran, Noa
Vij, Ravi
Doxie, Deon B.
Azeem, Maryam I.
Martillo, Mercedes https://orcid.org/0009-0009-3220-2997
Wozniak, Katie
Cho, Hearn J.
Dhodapkar, Kavita M. https://orcid.org/0000-0003-0587-4172
Dhodapkar, Madhav V. https://orcid.org/0000-0002-8249-5988
-
Funding
Funding for this research was provided by:
Leukemia and Lymphoma Society (SCOR)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA197603, CA138292, CA008748, CA238471)
Paula and Rodger Riney Foundation
- License Information
-
More Information
Article History
Received: 20 November 2023
Accepted: 5 August 2024
First Online: 26 August 2024
Competing interests
: M.V.D., consulting and advisory board for BMS, Lava Therapeutics and Sanofi. R.V., research support from BMS and Takeda; honoraria from Janssen, BMS, Sanofi, Karyopharm, Pfizer, GSK and Legend. J.L.K., consulting for BMS, Sanofi, Abbvie and Incyte. B.P., research funding from BMS; advisory boards for Janssen and Abbvie. N.B., consulting and advisory board for Janssen, Sanofi, Pfizer, Abbie and BMS; speaker bureau for Janssen, BMS and Pfizer; research support from Karyopharm, Amgen, BMS and Janssen. H.J.C., research support from Genentech, Roche, BMS and Takeda. H.J.C., K.W. and M.M. are employees of the MM Research Foundation. A.M.L., advisory roles for Pfizer, Arcellx and Janssen; research support from Pfizer and BMS; licenses and royalties from Caprion.
